For the year ending 2025-12-31, DFTX has $440,100K in assets. $107,773K in debts. $257,837K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 257,837 | |||
| Short-term investments | 153,756 | |||
| Prepaid and other current assets | 7,727 | |||
| Total current assets | 419,320 | |||
| Goodwill | 19,918 | |||
| Other non-current assets | 862 | |||
| Total assets | 440,100 | |||
| Accounts payable | 5,347 | |||
| Accrued expenses | 20,446 | |||
| 2022 usd financing warrants | 40,905 | |||
| Total current liabilities | 66,698 | |||
| Credit facility, long-term | 40,579 | |||
| Other non-current liabilities | 496 | |||
| Total liabilities | 107,773 | |||
| Additional paid-in capital | 913,914 | |||
| Accumulated other comprehensive income | 1,085 | |||
| Accumulated deficit | -582,672 | |||
| Total shareholders' equity | 332,327 | |||
| Total liabilities and shareholders' equity | 440,100 | |||
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)